@article{d8ee93f7cf55475990fce9585cc2f3a9,
title = "SNMMI/ACR/ASNC/SCMR Joint Credentialing Statement for Cardiac PET/MRI: Endorsed by the American Heart Association",
author = "Ruddy, \{Terrence D.\} and Mouaz Al-Mallah and Arrighi, \{James A.\} and Bois, \{John P.\} and Bluemke, \{David A.\} and \{Di Carli\}, \{Marcelo F.\} and Vasken Dilsizian and Gropler, \{Robert J.\} and Hossein Jadvar and Saurabh Malhotra and Matthier Pelletier-Galarneau and Schindler, \{Thomas H.\} and Woodard, \{Pamela K.\} and Panithaya Chareonthaitawee",
note = "Funding Information: Terrence D. Ruddy: GEHealthcare-Research Grant. Mouaz Al-Mallah: Research support: Siemens; Consultant: Pfizer, Jubulant, Philips. James A. Arrighi, John P. Bois, David A. Bluemke, Vasken Dilsizian: Nothing to disclose. Marcelo F. Di Carli: Institutional Research Grant: Gilead Sciences. Robert J. Gropler: GE-Healthcare and Medtrace—Research grants; American Society of Nuclear Cardiology-editor stipend. Hossein Jadvar: Radiomedix-Advisory Board; Lantheus-Speaker{\textquoteright}s Bureau; Blue Earth Diagnostics-Consultant; Bayer-Consultant. Saurabh Malhotra: Speakers Bureau—Pfizer Inc, and Alnylam; Advisory Board—Alnylam and BridgeBio. Matthieu Pelletier-Galarneau: Jubilant Radiopharma-Consulting, Research Funds. M.P.-G. is supported by a Junior 1 Research Award from the Fonds de Recherche du Qu{\'e}bec—Sant{\'e} (FRQS). Thomas H. Schindler: GE: multicenter Flupiridaz cardiac PET study. Pamela K. Woodard: None related to this article. Other research funding: NIH, Siemens, Bayer. Panithaya Chareonthaitawee: BioClinica-Consulting; UptoDate—Royalties.",
year = "2022",
month = aug,
day = "1",
doi = "10.1161/CIRCIMAGING.122.014576",
language = "English (US)",
volume = "15",
pages = "E014576",
journal = "Circulation: Cardiovascular Imaging",
issn = "1941-9651",
publisher = "Lippincott Williams and Wilkins",
number = "8",
}